Smith & Nephew SNATS (SNN) - Stock & Dividends
Exchange: USA Stocks • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US83175M2052
Smith & Nephew SNATS Inc (NYSE:SNN) is a company based in the United Kingdom that specializes in developing, manufacturing, and selling medical devices and services globally. With a history dating back to 1856, the company is headquartered in Watford, UK.
The company operates through three key segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Within these segments, Smith & Nephew offers a wide range of products, including knee and hip implants for joint replacement and revision surgeries, trauma and extremities products for fracture stabilization, sports medicine joint repair products for minimally invasive surgery, and advanced wound care products for acute and chronic wound treatment.
Moreover, Smith & Nephew provides arthroscopic enabling technologies like fluid management equipment, cameras, scopes, and tissue resection devices to improve visualization during surgical procedures. They also have ear, nose, and throat solutions to cater to a variety of medical needs.
Ultimately, Smith & Nephew primarily serves healthcare providers, offering a comprehensive portfolio of medical devices and services to address a wide range of medical conditions across different specialties.
For more information about Smith & Nephew SNATS Inc, you can visit their official website at https://www.smith-nephew.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
SNN Stock Overview
| Market Cap in USD | 10,700m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC SubIndustry | Health Care Equipment |
| TER | 0.00% |
| IPO / Inception | 1999-11-16 |
SNN Stock Ratings
| Growth 5y | -3.82 |
| Fundamental | 5.90 |
| Dividend | 5.89 |
| Rel. Performance vs Sector | -2.65 |
| Analysts | 4.25/5 |
| Fair Price Momentum | 20.54 USD |
| Fair Price DCF | 13.92 USD |
SNN Dividends
| Yield 12m | 3.15% |
| Yield on Cost 5y | 2.24% |
| Dividends CAGR 5y | 0.60% |
| Payout Consistency | 95.6% |
SNN Growth Ratios
| Growth 12m | -22.90% |
| Growth Correlation 12m | -37% |
| Growth Correlation 3m | -65% |
| CAGR 5y | -6.53% |
| Sharpe Ratio 12m | -1.26 |
| Alpha vs SP500 12m | -45.73 |
| Beta vs SP500 5y weekly | 1.06 |
| ValueRay RSI | 34.64 |
| Volatility GJR Garch 1y | 28.18% |
| Price / SMA 50 | -8.38% |
| Price / SMA 200 | -8.17% |
| Current Volume | 834.5k |
| Average Volume 20d | 976.2k |
External Links for SNN Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 20, 2024, the stock is trading at USD 23.84 with a total of 834,483 shares traded.
Over the past week, the price has changed by +0.29%, over one month by -9.78%, over three months by -13.75% and over the past year by -19.78%.
According to ValueRays Forecast Model, SNN Smith & Nephew SNATS will be worth about 22.7 in April 2025. The stock is currently trading at 23.84. This means that the stock has a potential downside of -4.66%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 31.5 | 32.1% |
| Analysts Target Price | 31.3 | 31.4% |
| ValueRay Target Price | 22.7 | -4.66% |